今日药学

2020, v.30(05) 320-323

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

1例新型冠状病毒肺炎合并常见慢病的患者药物治疗评价和监护
Evaluation and Monitoring of Drug Therapy in A Patient with COVID-19 with Common Chronic Disease

边原;熊堉;蒋敏;杨志勇;
BIAN Yuan;XIONG Yu;JIANG Min;YANG Zhiyong;Personalized Drug Therapy Key Laboratory of Sichuan Province,Department of Pharmacy,Sichuan Academy of Medical Sciences,Sichuan Provincial People's Hospital,Affiliated Hospital of University of Electronic Science and Technology of China;School of Medicine,University of Electronic Science and Technology of China;

摘要(Abstract):

自新型冠状病毒肺炎(COVID-19)疫情暴发以来,患者的监护治疗逐渐朝着科学化、规范化和合理化方向发展。在这个过程中,临床药师发挥着越来越重要的作用。因此,本文以1例合并常见慢病的COVID-19患者为例,分析其治疗方案,合并用药并提供药学监护,以期为临床药师参与COVID-19合并其他疾病的诊疗和监护提供参考。
Since the outbreak of COVID-19,the monitoring and treatment of patients has gradually developed towards scientific,standardized and rational direction. In this process,clinical pharmacists played an important role. Therefore,this paper took a COVID-19 patient with common chronic diseases as an example to analyze the treatment plan,medication and pharmaceutical care. In order to provide reference for clinical pharmacists to participate in the diagnosis and treatment of COVID-19 combined with other diseases.

关键词(KeyWords): 新型冠状病毒肺炎;常见慢病;临床药师;药物治疗评价;药学监护
COVID-19;common chronic diseases;clinical pharmacists;drug treatment evaluation;pharmaceutical care

Abstract:

Keywords:

基金项目(Foundation): 国家临床重点专科建设项目(30305030698);; 四川省省级公益性科研院所基本科研业务专项课题(2018YSKY0017);; 四川省人民医院院级科研基金临床研究及转化项目(2018LY09)

作者(Author): 边原;熊堉;蒋敏;杨志勇;
BIAN Yuan;XIONG Yu;JIANG Min;YANG Zhiyong;Personalized Drug Therapy Key Laboratory of Sichuan Province,Department of Pharmacy,Sichuan Academy of Medical Sciences,Sichuan Provincial People's Hospital,Affiliated Hospital of University of Electronic Science and Technology of China;School of Medicine,University of Electronic Science and Technology of China;

Email:

DOI:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享